![Carol Ashe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol Ashe
Direttore/Membro del Consiglio presso APTOSE BIOSCIENCES INC.
Patrimonio netto: 1 561 $ in data 31/05/2024
Posizioni attive di Carol Ashe
Società | Posizione | Inizio | Fine |
---|---|---|---|
APTOSE BIOSCIENCES INC. | Direttore/Membro del Consiglio | 15/08/2018 | - |
Independent Dir/Board Member | 15/08/2018 | - | |
ELICIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2020 | - |
Independent Dir/Board Member | 01/08/2020 | - | |
New York Genome Center
![]() New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2014 | - |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2020 | - |
Independent Dir/Board Member | 01/01/2020 | - |
Storia della carriera di Carol Ashe
Precedenti posizioni note di Carol Ashe
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENDO INTERNATIONAL PLC | Corporate Officer/Principal | 01/01/2011 | 01/01/2013 |
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investitore di Private Equity | - | 30/03/2010 |
GSK PLC | Corporate Officer/Principal | 01/01/2007 | 01/01/2008 |
Formazione di Carol Ashe
The Pennsylvania State University | Undergraduate Degree |
Villanova University School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Canada | 2 |
Irlanda | 2 |
Posizioni
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 3 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
APTOSE BIOSCIENCES INC. | Health Technology |
GSK PLC | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
GSK Equity Investments Ltd.
![]() GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
New York Genome Center
![]() New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Commercial Services |
Endo International Plc
![]() Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Carol Ashe
- Esperienza